NEW YORK (GenomeWeb News) – New Zealand cancer diagnostics firm Pacific Edge said today that its US subsidiary has finalized a deal with preferred provider organization FedMed to offer Pacific Edge's bladder cancer test in the US.
Registering provides access to this and other free content.
Already have an account?Login Now.
Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.
Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.
In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.
Iceland has nearly eliminated Down syndrome from its population, CBS News reports.